Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

I’m going to burst the bubble a little bit. Is it great to have Zack’s initiate this coverage? Absolutely? Will it lead to more eyes and more investors? Highly likely.

I would not say that Zack’s is a big respectable analyst firm. More of a C player. Having lived in the IR world, sell side analysts are who you want coverage from.

This article was good, but brief. Sell side analysts go in deep financial depth, project future share price ranges, risks, make recommendations for buy side, etc. The initial report was ok. Their negatives were questionable by someone who should know the company, but the additionally publicity is nice. It’s certainly a step in the right direction.